RRM1 and non-small cell lung carcinoma: For instance, Example-12 does not mention a disease, and so we extract the disease “NSCLC” from the title “RRM1 single nucleotide polymorphism -37C—>A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy”.